newsfilter
← Latest News
GlobeNewswire·

Bioasis Announces Filing of Its Quarterly Financial Statements and MD&A for the Period Ending November 30, 2022

NEW HAVEN, Conn., Jan. 19, 2023 (GLOBE NEWSWIRE) -- BIOASIS TECHNOLOGIES INC. (OTCQB:BIOAF, TSX.V:BTI)) (the "Company" or "Bioasis"), a multi-asset rare and orphan disease biopharmaceutical company developing clinical